Current Drug Safety

Editor-in-Chief:

Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia

Back

Editorial [Is Suicidality Serious?] promotion: free to download

Volume:4   Issue:2
Pp: 95-96
Frank M.C. Besag
DOI: 10.2174/157488609788173053

Determination of the Frequency and Direct Cost of the Adverse Drug Events in Argentina

Volume:4   Issue:2
Pp: 103-106
Estela Izquierdo, Claudio Rodriguez, Eneas Pampliega and Ester Filinger
DOI: 10.2174/157488609788173017

Predictors of “Worsening Renal Function” in Patients Hospitalized in Internal Medicine Department

Volume:4   Issue:2
Pp: 113-118
Waleed M. Sweileh, Ansam F. Sawalha, Hanadi M. Jayousi, Sa'ed H. Zyoud and Samah W. Al-Jabi
DOI: 10.2174/157488609788173071

A Case of Neuroleptic Malignant Syndrome Induced by Risperidone in a Schizophrenic Woman

Volume:4   Issue:2
Pp: 119-120
Luca Gallelli, Vincenzo Spagnuolo, Caterina Palleria, Giovambattista De Sarro and Maria Ferraro
DOI: 10.2174/157488609788173062

Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose Pravastatin

Volume:4   Issue:2
Pp: 121-122
Nasser Mikhail, Elizabeth Iskander and Dennis Cope
DOI: 10.2174/157488609788173080

Safety of Multi-Targeted Kinase Inhibitors as Monotherapy Treatment of Cancer: A Systematic Review of the Literature

Volume:4   Issue:2
Pp: 143-154
Sheila Crean, Dylan M. Boyd, Brian Sercus and Michael Lahn
DOI: 10.2174/157488609788173026